These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15008067)

  • 21. Determining sample size and power in clinical trials: the forgotten essential.
    Grimes DA; Schulz KF
    Semin Reprod Endocrinol; 1996 May; 14(2):125-31. PubMed ID: 8796935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis under the spotlight: focused on a meta-analysis of ventilator weaning.
    Tobin MJ; Jubran A
    Crit Care Med; 2008 Jan; 36(1):1-7. PubMed ID: 18007269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 'number needed to sample' in primary care research. Comparison of two primary care sampling frames for chronic back pain.
    Smith BH; Hannaford PC; Elliott AM; Smith WC; Chambers WA
    Fam Pract; 2005 Apr; 22(2):205-14. PubMed ID: 15722397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials. How should they be designed?
    Onken JE; Brazer SR
    Gastrointest Endosc Clin N Am; 1994 Apr; 4(2):423-34. PubMed ID: 8193874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A small p-value from an observed data is not evidence of adequate power for future similar-sized studies: a cautionary note.
    Atenafu EG; Hamid JS; Stephens D; To T; Beyene J
    Contemp Clin Trials; 2009 Mar; 30(2):155-7. PubMed ID: 19063996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Power analyses for correlations from clustered study designs.
    Tu XM; Kowalski J; Crits-Christoph P; Gallop R
    Stat Med; 2006 Aug; 25(15):2587-606. PubMed ID: 16025545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A necessary number or subjects... to conclude].
    Glemain P
    Prog Urol; 2001 Apr; 11(2):364-7. PubMed ID: 11400510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to assess the external validity of therapeutic trials: a conceptual approach.
    Dekkers OM; von Elm E; Algra A; Romijn JA; Vandenbroucke JP
    Int J Epidemiol; 2010 Feb; 39(1):89-94. PubMed ID: 19376882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of internal pilots with the univariate approach to repeated measures.
    Coffey CS; Muller KE
    Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roaming through methodology. XXXIII. Ethics of sample size estimation: less subjects needed for a one-sided than for a two-sided statistical investigation].
    Knottnerus JA; Bouter LM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1051-4. PubMed ID: 11414165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
    van der Lee JH; Wesseling J; Tanck MW; Offringa M
    J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncertainty in allometric exponent estimation: a case study in scaling metabolic rate with body mass.
    Hui D; Jackson RB
    J Theor Biol; 2007 Nov; 249(1):168-77. PubMed ID: 17720203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further statistics in dentistry. Part 4: Clinical trials 2.
    Petrie A; Bulman JS; Osborn JF
    Br Dent J; 2002 Nov; 193(10):557-61. PubMed ID: 12481177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.